🏦Change in Bank Control Act Notices for Business Acquisitions
This notice outlines applications for acquiring shares in banks or bank holding companies under the Change in Bank Control Act. It details the process for public commentary and information disclosure, emphasizing transparency and regulatory compliance within the banking sector. Interested parties are invited to submit comments regarding these applications before the specified deadline.
Learn More💰FICC's Proposed Intraday Mark-to-Market Charge
The SEC is reviewing the FICC's proposed rule change to implement an Intraday Mark-to-Market Charge, aimed at managing risk linked to fluctuating market conditions. This charge will affect margin calculations for its members and outlines specific thresholds under which it applies, prompting a new approach to credit exposure management and alert communications via public notices.
Learn More📜CFTC Notice on Information Collection and Compliance Requirements
In compliance with the Paperwork Reduction Act of 1995 ("PRA"), this notice announces that the Information Collection Request ("ICR") abstracted below has been forwarded to the Office of Information and Regulatory Affairs ("OIRA"), of the Office of Management and Budget ("OMB"), for review and comment. The ICR describes the nature of the information collection and its expected costs and burden.
Learn More🏥FDA Revokes EUA for Cepheid COVID-19 Diagnostic Device
The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorization (EUA) (the Authorization) issued to Cepheid for the Xpert Xpress SARS-CoV-2 test. FDA revoked the Authorization under the Federal Food, Drug, and Cosmetic Act (FD&C Act) as requested by the Authorization holder. The revocation, which includes an explanation of the reason for revocation, is reprinted at the end of this document.
Learn More📞Proposed Information Collection for National Human Trafficking Hotline
The Administration for Children and Families (ACF) is requesting a 3-year extension of an approved information collection: National Human Trafficking Hotline (NHTH) Performance Indicators (Office of Management and Budget (OMB) Number: 0970-0598, expiration October 31, 2025). There are no changes requested to the form.
Learn More⚡Combined Notice of Filings #2
The Department of Energy's Federal Energy Regulatory Commission issued a Combined Notice of Filings, detailing various electric rate and securities filings made by companies like ConocoPhillips and Pacific Gas and Electric. The notice includes important comment dates and procedural requirements for stakeholders to engage with the Commission on the described filings.
Learn More🪙Proposed Rule Change for Sprott Physical Copper Trust Trading
The SEC has announced a proposed rule change allowing NYSE Arca to list and trade shares of the Sprott Physical Copper Trust. This trust aims to invest primarily in physical copper, providing investors with a regulated investment option in the copper market. The initiative will enhance trading opportunities and may influence copper prices in broader markets.
Learn More🎣Notice of SEDAR 100 Pre-Data Workshop Webinar on Gulf Gray Triggerfish
The SEDAR 100 assessment process of Gulf gray triggerfish will consist of a Data Workshop, and a series of assessment webinars, and a Review Workshop. see SUPPLEMENTARY INFORMATION.
Learn More💵Overview of COVID-19 Provider Relief Fund Reporting Requirements
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
Learn More🧪FDA Classifies Herpes Simplex Virus Assay as Class II Device
The Food and Drug Administration (FDA, the Agency, or we) is classifying the herpes simplex virus nucleic acid-based assay for central nervous system infections into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the herpes simplex virus nucleic acid-based assay for central nervous system infections. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Learn More